NCT03967275View on ClinicalTrials.gov

Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions
Bone Marrow Donor
Interventions
OTHER

bone marrow harvest

During bone marrow harvest, an additional 10 mL sample will be collected for the study.

Trial Locations (1)

75010

Saint Louis Hospital, APHP, Paris

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT03967275 - Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn | Biotech Hunter | Biotech Hunter